All lobbying filings

CAREDX, INC.

CAREDX, INC. filed a Q1 report for CAREDX, INC. on April 20, 2026.

Lobbying for CAREDX, INC. · Clinical laboratory and transplant support services

All filings by CAREDX, INC. · Everything CAREDX, INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$140,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Lobbyists on this filing 1

KIMBERLY LINTHICUM

Previously held: LD, Rep. Bob Franks

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

-Medicare coverage of molecular testing for solid organ allograft rejection -Medicare payment of clinical laboratory tests; implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) -Prior authorization of molecular tests

Health Issues

Living Donor Protection Act (LDPA) S1522, HR4582,HR4583

Bills named in this filing 2

H.R. 4582
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surge…
H.R. 4583
Living Donor Protection Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.